Multiple Sclerosis Clinical Trial
— CERT-MSOfficial title:
Cognitive and Emotion Regulation Training in Multiple Sclerosis
Verified date | April 2018 |
Source | Ohio State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators propose to conduct a randomized feasibility study of mindfulness meditation training (MMT) relative to an active cognitive training control group and waitlist control group in improving emotional regulation in individuals with MS. Individuals will complete pre- and post-assessments of emotional functioning through a week of daily diary entries, as well as self-report measures and a behavioral paradigm. Additionally, all participants will complete an evaluation of neuropsychological functioning, before and after intervention.
Status | Completed |
Enrollment | 62 |
Est. completion date | May 14, 2017 |
Est. primary completion date | May 14, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 59 Years |
Eligibility |
Inclusion Criteria: 1. 30-59 years of age 2. Score higher than or equal to 23 on the Mini Mental Status Examination (MMSE) 3. Corrected (near and far) visual acuity of 20/40 or better 4. No previous experience with mindfulness or continuous meditation practice 5. Absence of other co-morbid neurological disorders 6. Relapse free for the last 30 days 7. No use of corticosteroids for the last 30 days 8. Clinically definite diagnosis of MS 9. Ability to use a computer and connect the internet from their home 10. Generation of at least two worries and two ruminations during the daily diary portion of the study for the pre-assessment session Exclusion Criteria: 1. Below 30 years of age or above 59 years of age 2. Score lower than 23 on the MMSE 3. Corrected (near or far) visual acuity of 20/40 or greater 4. Previous experience or participation in a mindfulness program 5. Presence of co-morbid neurological disorders such as: - Alzheimers - Parkinson's disease - Dementia 6. Presence of a relapse within the last 30 days 7. Use of corticosteroids within the last 30 days 8. Clinically isolated syndrome suggestive of MS 9. No ability to use a computer and/or a lack of internet connection from their home 10. No self-generated worries and ruminations in the week-long daily diary portion of the study at pre-assessment |
Country | Name | City | State |
---|---|---|---|
United States | Department of Psychology, The Ohio State University | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ohio State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Reported Engagement After Worry and Rumination Inductions | Participants will engage in worry and rumination inductions during both the pre- and post-intervention sessions. These worries and ruminations will be sampled from the daily diaries participants will fill out 7-days before the pre- and post-intervention sessions. Investigators will be examining the change in emotion and strategy implementation over the course of the worry and rumination inductions. Specifically, investigators will examine the change in reported negative and positive emotion related to the worry and rumination inductions from pre- to post-intervention. Further, investigators will examine the induction-related change in strategy implementation, specifically worry and rumination, over the 4-weeks of intervention. | Baseline and 4 weeks | |
Secondary | Cognitive Performance on Brief Repeatable Battery (BRB) | Participants will perform the entire Brief Repeatable Battery before and after the intervention. Using the categorization developed by Sepulcher (2013), the 5 tests of the BRB will be analyzed using four cognitive domains: attention and executive functioning, verbal memory, visual memory, and word fluency. Based on the computerized cognitive training protocol employed in the current study, investigators hypothesize changes in attention and executive functioning along with visual memory in participants in the cognitive training group, followed by participants in the MMT group compared with the wait-list control participants. | Baseline and 4 weeks | |
Secondary | Heart Rate Variability (HRV) | HRV data will be collected during worry and rumination inductions, as participants regulate their emotions, and at rest. | Baseline and 4 weeks | |
Secondary | Daily Emotion Regulation Diary | Participants will be asked to fill out worry and ruminations using a diary-based methodology a week before the pre-intervention behavioral session and one week after the post-intervention sessions. Changes in average self-reported worry and rumination intensity, emotion regulation strategy use, and successful emotion regulation strategy implementation will be examined as a function of the intervention. | Baseline and 4 weeks | |
Secondary | Improvements on a Self-Report Measure of Emotion Dysregulation | Emotion Dysregulation will be assessed using the Difficulties in Emotion Regulation Scale (DERS). Changes on the total score and sub-facets of DERS will be examined as a function of the intervention. | Baseline and 4 weeks | |
Secondary | Improvements on a Self-Report Measure of Depression | Participants will be administered Beck Depression Inventory before and after the intervention. Change on this measure will be examined to assess the impact of the interventions on symptoms of depression. | Baseline and 4 weeks | |
Secondary | Improvements on a Self-Report Measures of Anxiety | Participants will be administered Penn State Worry Questionnaire before and after the intervention. Change on this measure will be examined to assess the impact of the interventions on symptoms of worry. | Baseline and 4 weeks | |
Secondary | Improvements on a Self-Report Measure of Perceived Stress | Participants will be administered the Perceived Stress Scale before and after the intervention. Changes in these measures will be examined as a function of the intervention. | Baseline and 4 weeks | |
Secondary | Improvements on a Self-Report Measure of Quality of Life | Participants will be administered the Satisfaction with Life Scale before and after the intervention. Change in scores of this measure will be examined to assess changes in quality of life as a function of the interventions. | Baseline and 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|